Combination treatment of rituximab and imatinib mesylate for simultaneous relapse of MALT lymphoma and a gastrointestinal stromal tumor. [electronic resource]
Producer: 20050418Description: 2353-4 p. digitalISSN:- 1042-8194
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- biosynthesis
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzamides
- Cyclophosphamide -- administration & dosage
- Disease Progression
- Doxorubicin -- administration & dosage
- Female
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate
- Lymphoma -- metabolism
- Lymphoma, B-Cell, Marginal Zone -- drug therapy
- Middle Aged
- Piperazines -- administration & dosage
- Prednisolone -- administration & dosage
- Pyrimidines -- administration & dosage
- Recurrence
- Rituximab
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.